NEW YORK, NY / ACCESSWIRE / February 17, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Hanesbrands Inc. (NYSE: HBI), NiSource Inc. (NYSE: NI), Unilever PLC (NYSE: UL) and Quest Diagnostics Inc. (NYSE: DGX). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
HBI Research Package: http://www.traders-choice.com/pdf?s=HBI
NI Research Package: http://www.traders-choice.com/pdf?s=NI
UL Research Package: http://www.traders-choice.com/pdf?s=UL
DGX Research Package: http://www.traders-choice.com/pdf?s=DGX
============
Highlights from today's reports include:
On Tuesday, February 16, 2016, NASDAQ Composite ended at 4,435.96, up 2.27%, Dow Jones Industrial Average advanced 1.39%, to finish the day at 16,196.41, and the S&P 500 closed at 1,895.58, up 1.65%.
- Hanesbrands Inc.'s stock edged higher by 3.35% to close Tuesday's session at USD 27.47. The company's shares oscillated between USD 26.80 and USD 27.73. The stock recorded a trading volume of 5.10 million shares, which was above its 50-day daily average volume of 4.17 million shares and its 52-week average volume of 3.72 million shares. Over the last three days Hanesbrands Inc.'s shares have advanced 9.70% and in the past one week the stock has moved up 15.32%. However, over the last three months the stock has lost 9.10% and in the past six months the shares have shed 9.58%. Further, the company is trading at a price to earnings ratio of 25.92 and a price to book ratio of 8.16, compared to its historical PE ratio of 27.70 and a historical PB ratio of 9.03. Additionally, the stock is trading at a price to cash flow ratio of 18.21 and a price to sales ratio of 1.82.
- The stock of NiSource Inc. lost 0.80% to close Tuesday's session at USD 21.11. The shares of the company moved in the range of USD 20.96 and USD 21.56. A trading volume of 2.60 million shares was recorded, which was lower than its 150-day daily average volume of 3.19 million shares and its 52-week average volume of 4.15 million shares. Over the last five days NiSource Inc.'s shares have advanced 0.96% and in the past one month the stock has gained a momentum of 8.42%. Additionally, over the last three months the stock has advanced 10.06% and in the past six months the shares have registered a gain of 19.00%. Further, the company is trading at a price to earnings ratio of 17.45 and a price to book ratio of 1.78. Moreover, the stock is trading at a price to cash flow ratio of 4.85 and a price to sales ratio of 1.16.
- Unilever PLC's stock increased by 0.88% to close Tuesday's session at USD 43.38. The company's shares fluctuated in the range of USD 42.98 and USD 43.55. A total of 1.72 million shares exchanged hands, which surpassed its 50-day daily average volume of 1.53 million shares and its 52-week average volume of 1.16 million shares. Over the last three days Unilever PLC's shares have advanced 1.93% and in the past one week the stock has moved up 0.81%. Furthermore, over the last three months the stock has gained 1.33% while in the past six months the shares have shed 0.39%. Unilever PLC has a current dividend yield of 3.84%. Further, the company is trading at a price to earnings ratio of 22.71, compared to its historical PE ratio of 23.10. Additionally, the stock is trading above its 50-day and 200-day moving averages of USD 42.41 and USD 42.57, respectively.
- Quest Diagnostics Inc.'s stock added 2.13% to close Tuesday's session at USD 63.22. The share price vacillated between USD 61.92 and USD 63.57. The stock recorded a trading volume of 0.90 million shares, which was below its 50-day daily average volume of 1.12 million shares and its 52-week average volume of 1.29 million shares. Over the last five days Quest Diagnostics Inc.'s shares have advanced 4.43% while in the past one month the stock has lost 5.19%. In addition, over the last three months the stock has lost 7.08% and year to date the shares have shed 10.60%. Quest Diagnostics Inc. has a current dividend yield of 2.58% and a beta of 0.67. Further, the company is trading at a price to earnings ratio of 12.98 and a price to book ratio of 2.10, compared to its historical PE ratio of 14.55 and a historical PB ratio of 2.17.
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice